While addition of either αPD-L1 or Akt inhibitor did not significantly reduce the secondary tumor growth, combined treatment with αPD-L1 and Akt inhibitor significantly inhibited the secondary tumor growth when added to RT. Here, AKT1 is linked to neoplasm.